Published in

SAGE Publications, Australian and New Zealand Journal of Psychiatry, 7(39), p. 565-574

DOI: 10.1111/j.1440-1614.2005.01628.x

SAGE Publications, Australian and New Zealand Journal of Psychiatry, 7(39), p. 565-574, 2005

DOI: 10.1080/j.1440-1614.2005.01628.x

Links

Tools

Export citation

Search in Google Scholar

Acute Tryptophan Depletion. Part II: Clinical Effects and Implications

Journal article published in 2005 by Caroline J. Bell, Sean D. Hood ORCID, David J. Nutt
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Objective: This is the second of two articles reviewing the modern dietary technique of acute tryptophan depletion (ATD), a method of transiently reducing central serotonin levels in both healthy volunteers and clinical populations. This article details the clinical studies to date and discusses the implications of this research methodology. Method: The authors present a review of clinical ATD studies collated from a MEDLINE search, unpublished communications and the authors' considerable experience with this paradigm. Results: Following from the initial use of ATD in subjects with depressive illness, studies of anxiety disorders and other psychiatric illnesses have been reported. Sleep, aggressive and cognitive effects are also active areas of research and are reviewed here. Conclusions: Acute tryptophan depletion remains a useful psychiatric research tool. The findings from the clinical studies reviewed here are summarized and implications for future research detailed.